Mazieres J, Lafitte C, Ricordel C, Greillier L, et al. Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial. J Clin Oncol 2022 Jan 24:JCO2101455. doi: 10.1200/JCO.21.01455.
PMID: 35073148